Clinical Trial Results:
A 12-week randomised, evaluator-masked, parallel-group, multinational, multi-centre study comparing the efficacy and safety of the fixed combination of latanoprost and timolol (XalacomTM) with the fixed combination of dorzolamide and timolol (Cosopt®) in subjects with open-angle glaucoma or ocular hypertension.
Summary
|
|
EudraCT number |
2005-001128-35 |
Trial protocol |
DE SE IT |
Global completion date |
25 Jul 2006
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
08 Jul 2016
|
First version publication date |
13 Feb 2015
|
Other versions |
|
Summary report(s) |
Public Disclosure Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.